Baxdela (Delafloxacin Meglumine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Baxdela. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
Abemaciclib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Level 2 evidence
Acarbose
The therapeutic efficacy of Acarbose can be increased when used in combination with Delafloxacin.
Level 2 evidence
Acenocoumarol
The metabolism of Acenocoumarol can be increased when combined with Delafloxacin.
Level 1 evidence
Acetaminophen
Delafloxacin may increase the hepatotoxic activities of Acetaminophen.
Level 1 evidence
Adenine
The metabolism of Delafloxacin can be decreased when combined with Adenine.
Level 2 evidence
Afatinib
Afatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Level 2 evidence
Alectinib
Alectinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Level 2 evidence
Almasilate
Almasilate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be increased when used in combination with Delafloxacin.
Level 2 evidence
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Amikacin
Delafloxacin may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Enter your NPI to unlock 1 major interaction for Baxdela
Baxdela (Delafloxacin Meglumine) has 996 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Baxdela (Delafloxacin Meglumine) has 32 major, 375 moderate, and 589 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Baxdela. Always confirm against the full prescribing information.